Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 32 Records) |
| Query Trace: Diabetes Mellitus and CYP2C9[original query] |
|---|
| CYP4A11 polymorphism correlates with coronary endothelial dysfunction in patients with coronary artery disease--the ENCORE Trials. Atherosclerosis 2009 Dec 207 (2): 476-9. Hermann M, Hellermann J P, Quitzau K, Hoffmann M M, Gasser T, Meinertz T, Münzel T, Fleming I, Lüscher T |
| Presence of CYP2C9*3 allele increases risk for hypoglycemia in Type 2 diabetic patients treated with sulfonylureas. Pharmacogenomics 2009 Nov 10 (11): 1781-7. Ragia Georgia, Petridis Ioannis, Tavridou Anna, Christakidis Dimitrios, Manolopoulos Vangelis |
| Effect of CYP2C9 polymorphisms on prescribed dose and time-to-stable dose of sulfonylureas in primary care patients with Type 2 diabetes mellitus. Pharmacogenomics 2010 Nov 11 (11): 1517-23. Swen Jesse J, Wessels Judith A M, Krabben Annemarie, Assendelft Willem J J, Guchelaar Henk-J |
| Impact of CYP2C8 and 2C9 polymorphisms on coronary artery disease and myocardial infarction in the LURIC cohort. Pharmacogenomics 2010 Oct 11 (10): 1359-65. Haschke-Becher Elisabeth, Kirchheiner Julia, Trummer Olivia, Grünbacher Gerda, Kainz Alexander, Boehm Bernhard O, März Winfried, Renner Wilfri |
| Analysis of CYP2C9*2, CYP2C19*2, and CYP2D6*4 polymorphisms in patients with type 2 diabetes mellitus. Bosnian journal of basic medical sciences / Udruz?enje basic?nih mediciniskih znanosti = Association of Basic Medical Sciences 2010 Nov 10 (4): 287-91. Semiz Sabina, Dujic Tanja, Ostanek Barbara, Prnjavorac Besim, Bego Tamer, Malenica Maja, Marc Janja, Causevic Adli |
| Influence of CYP2C9 gene polymorphisms on response to glibenclamide in type 2 diabetes mellitus patients. European journal of clinical pharmacology 2011 Aug 67 (8): 797-801. Surendiran A, Pradhan S C, Agrawal Aparna, Subrahmanyam D K S, Rajan S, Anichavezhi D, Adithan |
| Association between cytochrome P450 promoter polymorphisms and ischemic stroke. Experimental and therapeutic medicine 2012 Feb 3 (2): 261-268. Kim Su Kang, Yim Sung-Vin, Lee Byung-Che |
| Effect of CYP2C9 and SLCO1B1 polymorphisms on the pharmacokinetics and pharmacodynamics of nateglinide in healthy Chinese male volunteers. European journal of clinical pharmacology 2013 Mar 69 (3): 407-13. Cheng Yu, Wang Guo, Zhang Wei, Fan Lan, Chen Yao, Zhou Hong-H |
| Interaction between ALOX5AP and CYP3A5 gene variants significantly increases the risk for cerebral infarctions in Chinese. Neuroreport 2014 May 25 (7): 452-7. Chi Li-Fen, Yi Xing-Yang, Shao Min-Jie, Lin Jing, Zhou Qia |
| A pharmacogenetics-based warfarin maintenance dosing algorithm from Northern Chinese patients. PloS one 2014 9 (8): e105250. Chen Jinxing, Shao Liying, Gong Ling, Luo Fang, Wang Jin'e, Shi Yi, Tan Yu, Chen Qianlong, Zhang Yu, Hui Rutai, Wang Yi |
| Investigating the Role of Plasma Glucose Concentration as a Phenotypic Marker for CYP2C9 Genetic Variants, in the Diabetic Population of Gujarat. Indian journal of pharmaceutical sciences 2014 Jan 76 (1): 72-7. Bhatt D, Chauhan N, Sharma A, Dhawan D, Bhatt R V, Phatak S, Padh |
| CYP2C9*2 allele increases risk for hypoglycemia in POR*1/*1 type 2 diabetic patients treated with sulfonylureas. Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 2014 Jan 122 (1): 60-3. Ragia G, Tavridou A, Elens L, Van Schaik R H N, Manolopoulos V |
| CYP2C8 rs17110453 and EPHX2 rs751141 two-locus interaction increases susceptibility to ischemic stroke. Gene 2015 Jul 565 (1): 85-9. Yi Xingyang, Zhang Biao, Wang Chun, Liao Duanxiu, Lin Jing, Chi Lif |
| Clinical Predictors Associated With Warfarin Sensitivity. American journal of therapeutics 2015 Mar . Saleh Mohammad |
| Risk factors for post-transplant diabetes mellitus in renal transplant: Role of genetic variability in the CYP450-mediated arachidonic acid metabolism. Molecular and cellular endocrinology 2015 Oct . Gervasini Guillermo, Luna Enrique, García-Cerrada Montserrat, Garcia-Pino Guadalupe, Cubero Juan Jo |
| Evaluation of the pharmacokinetics of glibenclamide tablet given, off label, orally to children suffering from neonatal syndromic hyperglycemia. European journal of clinical pharmacology 2016 Aug . Bouazza Naïm, Djerada Zoubir, Gozalo Claire, Busiah Kanetee, Beltrand Jacques, Berdugo Marianne, Urien Saik, Treluyer Jean-Marc, Polak Mich |
| CYP2C93 variant is associated with antidiabetes efficacy of gliclazide in Chinese type 2 diabetes patients. Journal of diabetes investigation 2016 Jan . Zeng Wotan, Guo Yali, Chen Peixian, Liu Zhike, Chen Dafang, Han Chun |
| Distribution of CYP2C8 and CYP2C9 amino acid substitution alleles in South Indian diabetes patients: A genotypic and computational protein phenotype study. Clinical and experimental pharmacology & physiology 2017 Jul . Rao Durga Koteswara, Murthy Dwarakanath K, Shaik Nazia Sultana, Banaganapalli Babajan, Konda Kumar Swami, Rao Hanumantha P, Ganti Eswar, Zuheir Ahmed A, El-Harouni Ashraf, Elango Ramu, Ali Khan Imran, Shaik Noor Ahm |
| Genetic and Non-Genetic Factors Affecting the Quality of Anticoagulation Control and Vascular Events in Atrial Fibrillation. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association 2017 Apr . Park Yun Kyung, Lee Mi Ji, Kim Jae Ha, Lee Jin Soo, Park Rae Woong, Kim Gyeong-Moon, Chung Chin-Sang, Lee Kwang Ho, Kim June Soo, Lee Soo-Youn, Bang Oh You |
| Interaction among CYP2C8, GPIIIa and P2Y12 variants increase susceptibility to ischemic stroke in Chinese population. Oncotarget 2017 Sep 8 (41): 70811-70820. Yi Xingyang, Lin Jing, Wang Yanfen, Zhou Ju, Zhou Qia |
| Frequency of CYP2C9 (*2, *3 and IVS8-109A>T) allelic variants, and their clinical implications, among Mexican patients with diabetes mellitus type 2 undergoing treatment with glibenclamide and metformin. Biomedical reports 2019 5 10 (5): 283-295. Cuautle-Rodríguez Patricia, Rodríguez-Rivera Nidia, De Andrés Fernando, Castillo-Nájera Fernando, Llerena Adrián, Molina-Guarneros Juan Arcad |
| Pharmacogenetics of hypoglycemia associated with sulfonylurea therapy in usual clinical care. The pharmacogenomics journal 2020 Jun . Mitchell Sabrina L, Leon Daniel A Carranza, Chaugai Sandip, Kawai Vivian K, Levinson Rebecca T, Wei Wei-Qi, Stein C Micha |
| rs622342 in SLC22A1, CYP2C9*2 and CYP2C9*3 and Glycemic Response in Individuals with Type 2 Diabetes Mellitus Receiving Metformin/Sulfonylurea Combination Therapy: 6-Month Follow-Up Study. Journal of personalized medicine 2020 6 10 (2): . Naja Khaled, Salami Ali, El Shamieh Said, Fakhoury Raj |
| Assessment of pharmacogenomic SLCO1B1 assay for prediction of neuromuscular pain in type 2 diabetes mellitus and cardiovascular patients: preliminary results. European review for medical and pharmacological sciences 2020 Jan 24 (1): 469-477. Licito A, Marotta G, Battaglia M, Benincasa G, Mentone L, Grillo M R, De Lucia V, Leonardi G, Bignucolo A, Comello F, Di Francia R, De Lucia |
| Evaluation of the effect of MTNR1B rs10830963 gene variant on the therapeutic efficacy of nateglinide in treating type 2 diabetes among Chinese Han patients. BMC medical genomics 2021 Jun 14 (1): 156. Song Jin-Fang, Zhang Jie, Zhang Ming-Zhu, Ni Jiang, Wang Tao, Zhao Yi-Qing, Khan Naveed Ull |
| Association Between the CYP2C9 Genotype and Hypoglycemia Among Patients With Type 2 Diabetes Receiving Sulfonylurea Treatment: A Meta-analysis. Clinical therapeutics 2021 Apr . Yee Jeong, Heo Yunhee, Kim Hamin, Yoon Ha Young, Song Gonjin, Gwak Hye S |
| A pharmacogenetic pilot study of CYP2C9 common genetic variant and sulfonylureas therapeutic response in type 2 diabetes mellitus patients. Journal of diabetes and metabolic disorders 2021 12 20 (2): 1513-1519. Didari Elham, Sarhangi Negar, Afshari Mahdi, Aghaei Meybodi Hamid Reza, Hasanzad Manda |
| Development of pharmacogenomic algorithm to optimize nateglinide dose for the treatment of type 2 diabetes mellitus. Pharmacological reports : PR 2022 8 74 (5): 1083-1091. Naushad Shaik Mohammad, Hussain Tajamul, Alrokayan Salman A, Kutala Vijay Kum |
| Association of CYP2C9*2 Allele with Sulphonylurea-Induced Hypoglycaemia in Type 2 Diabetes Mellitus Patients: A Pharmacogenetic Study in Pakistani Pashtun Population. Biomedicines 2023 8 11 (8): . Asif Jan, Muhammad Saeed, Ramzi A Mothana, Tahir Muhammad, Naveed Rahman, Abdullah R Alanzi, Rani Akb |
| Genetic variants in epoxyeicosatrienoic acid processing and degradation pathways are associated with gestational diabetes mellitus. Nutrition journal 2023 6 22 (1): 31. Siyu Lai, Dandan Yan, Jie Xu, Xiangtian Yu, Jingyi Guo, Xiangnan Fang, Mengyang Tang, Rong Zhang, Hong Zhang, Weiping Jia, Mingjuan Luo, Cheng |
- Page last reviewed:Feb 1, 2023
- Page last updated:Sep 25, 2023
- Content source: